A 57-year-old woman reported a 'decreased ability to sleep' for the past 6 months, adding that she had never suffered from insomnia earlier. She also suffered from a few additional symptoms: fatigue, irritability and an occasional 'headache' all of which she attributed to be resultant of her reduced ability to sleep. However, when she had a sudden onset of blurred vision and vomiting for the past 1 month, she visited her physician. Her history was significant for having been treated 9 years ago for T 1 N 0 M 0 -staged breast cancer, with breastconservation surgery, radiotherapy and adjuvant tamoxifen for 5 years.
DESCRIPTION
A 57-year-old woman reported a 'decreased ability to sleep' for the past 6 months, adding that she had never suffered from insomnia earlier. She also suffered from a few additional symptoms: fatigue, irritability and an occasional 'headache' all of which she attributed to be resultant of her reduced ability to sleep. However, when she had a sudden onset of blurred vision and vomiting for the past 1 month, she visited her physician. Her history was significant for having been treated 9 years ago for T 1 N 0 M 0 -staged breast cancer, with breastconservation surgery, radiotherapy and adjuvant tamoxifen for 5 years.
MRI revealed a mass lesion (measuring 2.3 cm in its greatest diameter) occupying the region of the pineal gland ( figure 1 ). This was hypointense/isointense on fluid attenuated inversion recovery, T1-weighted and T2-weighted images in comparison with grey-matter, with intense heterogeneous postcontrast enhancement. There appeared to be obstructive hydrocephalus-with dilated third and lateral ventricles ( figure 2 ). An image-guided stereotactic biopsy confirmed metastaticcarcinoma, which was positive for oestrogen and progesterone receptors. ▸ Metastases to the pineal gland are a rare phenomenon. 2 Stereotactic biopsy is a feasible option to establish histopathology among patients with pineal gland mass lesions. ▸ Annual follow-up of patients treated for breast cancer is to be continued indefinitely, since it offers not only an opportunity to examine the patient with regard to breast cancer but also a chance to monitor the side effects of long-term hormonal manipulation, which include a higher-risk of osteoporosis and an increased risk of endometrial carcinoma.
